Breakthrough In Experimental HIV Vaccine Prevents Infections In 31% Of Cases
September 25, 2009 by admin
A phase III efficacy trial organized by the U.S. Military HIV Research Program and the Thai Ministry of Public Health, involving 16,000 volunteers in Thailand has revealed that volunteers who received a prime-boost combination of two AIDS vaccine candidates – ALVAC combined with AIDSVAX – had infection rates 31.2% lower than people who received a placebo.
Source: Breakthrough In Experimental HIV Vaccine Prevents Infections In 31% Of Cases
Comments
Feel free to leave a comment...
and oh, if you want a pic to show with your comment, go get a gravatar!